SCHEMBL14149752

SCHEMBL14149752

COc1ccc(-c2ccc(-c3ccccc3)cc2C)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 3/20 0.56
ABL1 P00519 2/20 0.53
ABCB1 P08183 2/20 0.53
BCR P11274 2/20 0.53
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.50
ACACA Q13085 1/20 0.50
MITF O75030 1/20 0.50
HTT P42858 1/20 0.50
ESR2 Q92731 1/20 0.50
CYP11B1 P15538 1/20 0.47
CYP11B2 P19099 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
POLB P06746 1/20 0.47
HDAC4 P56524 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22073083 0.93 DYRK1A (0.52) BACE1ABL1ABCB1BCRNPC1
SCHEMBL13463285 0.87 ACHE (0.56) ABL1ABCB1BCRNPC1RAB9A
SCHEMBL7822185 0.87 ESR2 (0.55) BACE1ABL1ABCB1BCRNPC1
SCHEMBL16192737 0.87 ESR2 (0.63) BACE1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL5013854 0.87 ESR2 (0.63) BACE1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL14953648 0.86 BACE1 (0.43) BACE1ABL1ABCB1BCRNPC1
SCHEMBL10802577 0.85 ABL1 (0.61) BACE1ABL1ABCB1BCRNPC1
SCHEMBL679848 0.83 SMN1; SMN2 (0.55) BACE1ABL1ABCB1BCRNPC1
SCHEMBL27649742 0.81 ABL1 (0.77) BACE1ABL1ABCB1BCRNPC1
SCHEMBL9152375 0.80 CA4 (0.68) BACE1ABL1ABCB1BCRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120302752-A1 Compounds and Methods for Catalytic Directed ortho Substitution of Aromatic Amides and Esters QUEEN'S UNIVERSITY AT KINGSTON (CA) 2012-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120302752-A1 Compounds and Methods for Catalytic Directed ortho Substitution of Aromatic Amides and Esters DDC, AOC2, AOC3 BACE1 3978/4885ABL1 588/4885ABCB1 3587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.